Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Edwards

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: optimization of cellular potencyMichael K Ameriks, Hui Cai, James P Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elementsMichael K Ameriks, Frank U Axe, Scott D Bembenek, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2011
Tricyclic aminopyrimidine histamine H4 receptor antagonistsBrad M Savall, Laurent Gomez, Frank Chavez, et al.
Journal of Medicinal Chemistry|September 5, 2003
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulatorsLin Zhi, Christopher M Tegley, Barbara Pio, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitorsDanielle K Wiener, Alice Lee-Dutra, Scott Bembenek, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2020
A carboxylic acid isostere screen of the DHODH inhibitor BrequinarLindsey G DeRatt, E Christine Pietsch, Alexandra Tanner, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Identification of a potent and selective noncovalent cathepsin S inhibitorRobin L Thurmond, Siquan Sun, Clark A Sehon, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regionsJohn J M Wiener, Alvah T Wickboldt, Danielle K Wiener, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitorsDarin J Gustin, Clark A Sehon, Jianmei Wei, et al.
Molecular Cancer Therapeutics|March 19, 2008
A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarkerShelby Crawford, Daniel Belajic, Jianmei Wei, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: optimization of cellular potencyMichael K Ameriks, Hui Cai, James P Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elementsMichael K Ameriks, Frank U Axe, Scott D Bembenek, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2011
Tricyclic aminopyrimidine histamine H4 receptor antagonistsBrad M Savall, Laurent Gomez, Frank Chavez, et al.
Journal of Medicinal Chemistry|September 5, 2003
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulatorsLin Zhi, Christopher M Tegley, Barbara Pio, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitorsDanielle K Wiener, Alice Lee-Dutra, Scott Bembenek, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2020
A carboxylic acid isostere screen of the DHODH inhibitor BrequinarLindsey G DeRatt, E Christine Pietsch, Alexandra Tanner, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Identification of a potent and selective noncovalent cathepsin S inhibitorRobin L Thurmond, Siquan Sun, Clark A Sehon, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regionsJohn J M Wiener, Alvah T Wickboldt, Danielle K Wiener, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitorsDarin J Gustin, Clark A Sehon, Jianmei Wei, et al.
Molecular Cancer Therapeutics|March 19, 2008
A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarkerShelby Crawford, Daniel Belajic, Jianmei Wei, et al.
Pageof 8